PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34575229-1	2021	This study aims to evaluate the relationship between human ribophorin II (RPN2) and the effect of treatment using induction therapy with docetaxel, cisplatin, and fluorouracil (TPF) for p-16 negative locally advanced head and neck squamous cell carcinoma (HNSCC).	TPF	177-180	ribophorin II	Homo sapiens	59-72	
34575229-1	2021	This study aims to evaluate the relationship between human ribophorin II (RPN2) and the effect of treatment using induction therapy with docetaxel, cisplatin, and fluorouracil (TPF) for p-16 negative locally advanced head and neck squamous cell carcinoma (HNSCC).	TPF	177-180	ribophorin II	Homo sapiens	74-78	
34575229-4	2021	Our study showed that RPN2 overexpression was significantly correlated with a poor response to induction chemotherapy with TPF.	TPF	123-126	ribophorin II	Homo sapiens	22-26